img

Global Soft Capsules Drugs CMO Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Soft Capsules Drugs CMO Market Insights, Forecast to 2034

The company supply Softgel Capsule contract pharmaceutical manufacturing services
Market Analysis and InsightsGlobal Soft Capsules Drugs CMO Market
Global Soft Capsules Drugs CMO market is expected to reach to US$ 8033 million in 2023, with a positive growth of %, compared with US$ 7651 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Soft Capsules Drugs CMO industry is evaluated to reach US$ 10760 million in 2033. The CAGR will be 5.0% during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Soft Capsules Drugs CMO market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Soft Capsules Drugs CMO market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Catalent
Aenova
Nature's Bounty
Procaps
Patheon (Thermo Fisher Scientific)
IVC
EuroCaps
Captek
Strides Pharma Science
Lonza (Capsugel)
Soft Gel Technologies
Sirio Pharma
Segment by Type
Gelatin Type
Non-animal Type

Segment by Application


Health Supplements
Pharmaceutical
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Soft Capsules Drugs CMO introduction, etc. Soft Capsules Drugs CMO Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Soft Capsules Drugs CMO
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Soft Capsules Drugs CMO Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Gelatin Type
1.2.3 Non-animal Type
1.3 Market by Application
1.3.1 Global Soft Capsules Drugs CMO Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Health Supplements
1.3.3 Pharmaceutical
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Soft Capsules Drugs CMO Market Perspective (2018-2033)
2.2 Global Soft Capsules Drugs CMO Growth Trends by Region
2.2.1 Soft Capsules Drugs CMO Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Soft Capsules Drugs CMO Historic Market Size by Region (2018-2023)
2.2.3 Soft Capsules Drugs CMO Forecasted Market Size by Region (2024-2033)
2.3 Soft Capsules Drugs CMO Market Dynamics
2.3.1 Soft Capsules Drugs CMO Industry Trends
2.3.2 Soft Capsules Drugs CMO Market Drivers
2.3.3 Soft Capsules Drugs CMO Market Challenges
2.3.4 Soft Capsules Drugs CMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Soft Capsules Drugs CMO by Players
3.1.1 Global Soft Capsules Drugs CMO Revenue by Players (2018-2023)
3.1.2 Global Soft Capsules Drugs CMO Revenue Market Share by Players (2018-2023)
3.2 Global Soft Capsules Drugs CMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Soft Capsules Drugs CMO, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Soft Capsules Drugs CMO Market Concentration Ratio
3.4.1 Global Soft Capsules Drugs CMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Soft Capsules Drugs CMO Revenue in 2022
3.5 Global Key Players of Soft Capsules Drugs CMO Head office and Area Served
3.6 Global Key Players of Soft Capsules Drugs CMO, Product and Application
3.7 Global Key Players of Soft Capsules Drugs CMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Soft Capsules Drugs CMO Breakdown Data by Type
4.1 Global Soft Capsules Drugs CMO Historic Market Size by Type (2018-2023)
4.2 Global Soft Capsules Drugs CMO Forecasted Market Size by Type (2024-2033)
5 Soft Capsules Drugs CMO Breakdown Data by Application
5.1 Global Soft Capsules Drugs CMO Historic Market Size by Application (2018-2023)
5.2 Global Soft Capsules Drugs CMO Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Soft Capsules Drugs CMO Market Size (2018-2033)
6.2 North America Soft Capsules Drugs CMO Market Size by Type
6.2.1 North America Soft Capsules Drugs CMO Market Size by Type (2018-2023)
6.2.2 North America Soft Capsules Drugs CMO Market Size by Type (2024-2033)
6.2.3 North America Soft Capsules Drugs CMO Market Share by Type (2018-2033)
6.3 North America Soft Capsules Drugs CMO Market Size by Application
6.3.1 North America Soft Capsules Drugs CMO Market Size by Application (2018-2023)
6.3.2 North America Soft Capsules Drugs CMO Market Size by Application (2024-2033)
6.3.3 North America Soft Capsules Drugs CMO Market Share by Application (2018-2033)
6.4 North America Soft Capsules Drugs CMO Market Size by Country
6.4.1 North America Soft Capsules Drugs CMO Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Soft Capsules Drugs CMO Market Size by Country (2018-2023)
6.4.3 North America Soft Capsules Drugs CMO Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Soft Capsules Drugs CMO Market Size (2018-2033)
7.2 Europe Soft Capsules Drugs CMO Market Size by Type
7.2.1 Europe Soft Capsules Drugs CMO Market Size by Type (2018-2023)
7.2.2 Europe Soft Capsules Drugs CMO Market Size by Type (2024-2033)
7.2.3 Europe Soft Capsules Drugs CMO Market Share by Type (2018-2033)
7.3 Europe Soft Capsules Drugs CMO Market Size by Application
7.3.1 Europe Soft Capsules Drugs CMO Market Size by Application (2018-2023)
7.3.2 Europe Soft Capsules Drugs CMO Market Size by Application (2024-2033)
7.3.3 Europe Soft Capsules Drugs CMO Market Share by Application (2018-2033)
7.4 Europe Soft Capsules Drugs CMO Market Size by Country
7.4.1 Europe Soft Capsules Drugs CMO Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Soft Capsules Drugs CMO Market Size by Country (2018-2023)
7.4.3 Europe Soft Capsules Drugs CMO Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Soft Capsules Drugs CMO Market Size (2018-2033)
8.2 China Soft Capsules Drugs CMO Market Size by Type
8.2.1 China Soft Capsules Drugs CMO Market Size by Type (2018-2023)
8.2.2 China Soft Capsules Drugs CMO Market Size by Type (2024-2033)
8.2.3 China Soft Capsules Drugs CMO Market Share by Type (2018-2033)
8.3 China Soft Capsules Drugs CMO Market Size by Application
8.3.1 China Soft Capsules Drugs CMO Market Size by Application (2018-2023)
8.3.2 China Soft Capsules Drugs CMO Market Size by Application (2024-2033)
8.3.3 China Soft Capsules Drugs CMO Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Soft Capsules Drugs CMO Market Size (2018-2033)
9.2 Asia Soft Capsules Drugs CMO Market Size by Type
9.2.1 Asia Soft Capsules Drugs CMO Market Size by Type (2018-2023)
9.2.2 Asia Soft Capsules Drugs CMO Market Size by Type (2024-2033)
9.2.3 Asia Soft Capsules Drugs CMO Market Share by Type (2018-2033)
9.3 Asia Soft Capsules Drugs CMO Market Size by Application
9.3.1 Asia Soft Capsules Drugs CMO Market Size by Application (2018-2023)
9.3.2 Asia Soft Capsules Drugs CMO Market Size by Application (2024-2033)
9.3.3 Asia Soft Capsules Drugs CMO Market Share by Application (2018-2033)
9.4 Asia Soft Capsules Drugs CMO Market Size by Region
9.4.1 Asia Soft Capsules Drugs CMO Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Soft Capsules Drugs CMO Market Size by Region (2018-2023)
9.4.3 Asia Soft Capsules Drugs CMO Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Soft Capsules Drugs CMO Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Soft Capsules Drugs CMO Market Size by Type
10.2.1 Middle East, Africa, and Latin America Soft Capsules Drugs CMO Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Soft Capsules Drugs CMO Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Soft Capsules Drugs CMO Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Soft Capsules Drugs CMO Market Size by Application
10.3.1 Middle East, Africa, and Latin America Soft Capsules Drugs CMO Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Soft Capsules Drugs CMO Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Soft Capsules Drugs CMO Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Soft Capsules Drugs CMO Market Size by Country
10.4.1 Middle East, Africa, and Latin America Soft Capsules Drugs CMO Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Soft Capsules Drugs CMO Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Soft Capsules Drugs CMO Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Details
11.1.2 Catalent Business Overview
11.1.3 Catalent Soft Capsules Drugs CMO Introduction
11.1.4 Catalent Revenue in Soft Capsules Drugs CMO Business (2018-2023)
11.1.5 Catalent Recent Developments
11.2 Aenova
11.2.1 Aenova Company Details
11.2.2 Aenova Business Overview
11.2.3 Aenova Soft Capsules Drugs CMO Introduction
11.2.4 Aenova Revenue in Soft Capsules Drugs CMO Business (2018-2023)
11.2.5 Aenova Recent Developments
11.3 Nature's Bounty
11.3.1 Nature's Bounty Company Details
11.3.2 Nature's Bounty Business Overview
11.3.3 Nature's Bounty Soft Capsules Drugs CMO Introduction
11.3.4 Nature's Bounty Revenue in Soft Capsules Drugs CMO Business (2018-2023)
11.3.5 Nature's Bounty Recent Developments
11.4 Procaps
11.4.1 Procaps Company Details
11.4.2 Procaps Business Overview
11.4.3 Procaps Soft Capsules Drugs CMO Introduction
11.4.4 Procaps Revenue in Soft Capsules Drugs CMO Business (2018-2023)
11.4.5 Procaps Recent Developments
11.5 Patheon (Thermo Fisher Scientific)
11.5.1 Patheon (Thermo Fisher Scientific) Company Details
11.5.2 Patheon (Thermo Fisher Scientific) Business Overview
11.5.3 Patheon (Thermo Fisher Scientific) Soft Capsules Drugs CMO Introduction
11.5.4 Patheon (Thermo Fisher Scientific) Revenue in Soft Capsules Drugs CMO Business (2018-2023)
11.5.5 Patheon (Thermo Fisher Scientific) Recent Developments
11.6 IVC
11.6.1 IVC Company Details
11.6.2 IVC Business Overview
11.6.3 IVC Soft Capsules Drugs CMO Introduction
11.6.4 IVC Revenue in Soft Capsules Drugs CMO Business (2018-2023)
11.6.5 IVC Recent Developments
11.7 EuroCaps
11.7.1 EuroCaps Company Details
11.7.2 EuroCaps Business Overview
11.7.3 EuroCaps Soft Capsules Drugs CMO Introduction
11.7.4 EuroCaps Revenue in Soft Capsules Drugs CMO Business (2018-2023)
11.7.5 EuroCaps Recent Developments
11.8 Captek
11.8.1 Captek Company Details
11.8.2 Captek Business Overview
11.8.3 Captek Soft Capsules Drugs CMO Introduction
11.8.4 Captek Revenue in Soft Capsules Drugs CMO Business (2018-2023)
11.8.5 Captek Recent Developments
11.9 Strides Pharma Science
11.9.1 Strides Pharma Science Company Details
11.9.2 Strides Pharma Science Business Overview
11.9.3 Strides Pharma Science Soft Capsules Drugs CMO Introduction
11.9.4 Strides Pharma Science Revenue in Soft Capsules Drugs CMO Business (2018-2023)
11.9.5 Strides Pharma Science Recent Developments
11.10 Lonza (Capsugel)
11.10.1 Lonza (Capsugel) Company Details
11.10.2 Lonza (Capsugel) Business Overview
11.10.3 Lonza (Capsugel) Soft Capsules Drugs CMO Introduction
11.10.4 Lonza (Capsugel) Revenue in Soft Capsules Drugs CMO Business (2018-2023)
11.10.5 Lonza (Capsugel) Recent Developments
11.11 Soft Gel Technologies
11.11.1 Soft Gel Technologies Company Details
11.11.2 Soft Gel Technologies Business Overview
11.11.3 Soft Gel Technologies Soft Capsules Drugs CMO Introduction
11.11.4 Soft Gel Technologies Revenue in Soft Capsules Drugs CMO Business (2018-2023)
11.11.5 Soft Gel Technologies Recent Developments
11.12 Sirio Pharma
11.12.1 Sirio Pharma Company Details
11.12.2 Sirio Pharma Business Overview
11.12.3 Sirio Pharma Soft Capsules Drugs CMO Introduction
11.12.4 Sirio Pharma Revenue in Soft Capsules Drugs CMO Business (2018-2023)
11.12.5 Sirio Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Soft Capsules Drugs CMO Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Gelatin Type
Table 3. Key Players of Non-animal Type
Table 4. Global Soft Capsules Drugs CMO Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Soft Capsules Drugs CMO Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Soft Capsules Drugs CMO Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Soft Capsules Drugs CMO Market Share by Region (2018-2023)
Table 8. Global Soft Capsules Drugs CMO Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Soft Capsules Drugs CMO Market Share by Region (2024-2033)
Table 10. Soft Capsules Drugs CMO Market Trends
Table 11. Soft Capsules Drugs CMO Market Drivers
Table 12. Soft Capsules Drugs CMO Market Challenges
Table 13. Soft Capsules Drugs CMO Market Restraints
Table 14. Global Soft Capsules Drugs CMO Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Soft Capsules Drugs CMO Revenue Share by Players (2018-2023)
Table 16. Global Top Soft Capsules Drugs CMO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soft Capsules Drugs CMO as of 2022)
Table 17. Global Soft Capsules Drugs CMO Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Soft Capsules Drugs CMO Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Soft Capsules Drugs CMO, Headquarters and Area Served
Table 20. Global Key Players of Soft Capsules Drugs CMO, Product and Application
Table 21. Global Key Players of Soft Capsules Drugs CMO, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Soft Capsules Drugs CMO Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Soft Capsules Drugs CMO Revenue Market Share by Type (2018-2023)
Table 25. Global Soft Capsules Drugs CMO Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Soft Capsules Drugs CMO Revenue Market Share by Type (2024-2033)
Table 27. Global Soft Capsules Drugs CMO Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Soft Capsules Drugs CMO Revenue Share by Application (2018-2023)
Table 29. Global Soft Capsules Drugs CMO Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Soft Capsules Drugs CMO Revenue Share by Application (2024-2033)
Table 31. North America Soft Capsules Drugs CMO Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Soft Capsules Drugs CMO Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Soft Capsules Drugs CMO Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Soft Capsules Drugs CMO Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Soft Capsules Drugs CMO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Soft Capsules Drugs CMO Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Soft Capsules Drugs CMO Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Soft Capsules Drugs CMO Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Soft Capsules Drugs CMO Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Soft Capsules Drugs CMO Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Soft Capsules Drugs CMO Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Soft Capsules Drugs CMO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Soft Capsules Drugs CMO Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Soft Capsules Drugs CMO Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Soft Capsules Drugs CMO Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Soft Capsules Drugs CMO Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Soft Capsules Drugs CMO Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Soft Capsules Drugs CMO Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Soft Capsules Drugs CMO Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Soft Capsules Drugs CMO Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Soft Capsules Drugs CMO Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Soft Capsules Drugs CMO Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Soft Capsules Drugs CMO Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Soft Capsules Drugs CMO Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Soft Capsules Drugs CMO Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Soft Capsules Drugs CMO Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Soft Capsules Drugs CMO Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Soft Capsules Drugs CMO Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Soft Capsules Drugs CMO Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Soft Capsules Drugs CMO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Soft Capsules Drugs CMO Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Soft Capsules Drugs CMO Market Size by Country (2024-2033) & (US$ Million)
Table 63. Catalent Company Details
Table 64. Catalent Business Overview
Table 65. Catalent Soft Capsules Drugs CMO Product
Table 66. Catalent Revenue in Soft Capsules Drugs CMO Business (2018-2023) & (US$ Million)
Table 67. Catalent Recent Developments
Table 68. Aenova Company Details
Table 69. Aenova Business Overview
Table 70. Aenova Soft Capsules Drugs CMO Product
Table 71. Aenova Revenue in Soft Capsules Drugs CMO Business (2018-2023) & (US$ Million)
Table 72. Aenova Recent Developments
Table 73. Nature's Bounty Company Details
Table 74. Nature's Bounty Business Overview
Table 75. Nature's Bounty Soft Capsules Drugs CMO Product
Table 76. Nature's Bounty Revenue in Soft Capsules Drugs CMO Business (2018-2023) & (US$ Million)
Table 77. Nature's Bounty Recent Developments
Table 78. Procaps Company Details
Table 79. Procaps Business Overview
Table 80. Procaps Soft Capsules Drugs CMO Product
Table 81. Procaps Revenue in Soft Capsules Drugs CMO Business (2018-2023) & (US$ Million)
Table 82. Procaps Recent Developments
Table 83. Patheon (Thermo Fisher Scientific) Company Details
Table 84. Patheon (Thermo Fisher Scientific) Business Overview
Table 85. Patheon (Thermo Fisher Scientific) Soft Capsules Drugs CMO Product
Table 86. Patheon (Thermo Fisher Scientific) Revenue in Soft Capsules Drugs CMO Business (2018-2023) & (US$ Million)
Table 87. Patheon (Thermo Fisher Scientific) Recent Developments
Table 88. IVC Company Details
Table 89. IVC Business Overview
Table 90. IVC Soft Capsules Drugs CMO Product
Table 91. IVC Revenue in Soft Capsules Drugs CMO Business (2018-2023) & (US$ Million)
Table 92. IVC Recent Developments
Table 93. EuroCaps Company Details
Table 94. EuroCaps Business Overview
Table 95. EuroCaps Soft Capsules Drugs CMO Product
Table 96. EuroCaps Revenue in Soft Capsules Drugs CMO Business (2018-2023) & (US$ Million)
Table 97. EuroCaps Recent Developments
Table 98. Captek Company Details
Table 99. Captek Business Overview
Table 100. Captek Soft Capsules Drugs CMO Product
Table 101. Captek Revenue in Soft Capsules Drugs CMO Business (2018-2023) & (US$ Million)
Table 102. Captek Recent Developments
Table 103. Strides Pharma Science Company Details
Table 104. Strides Pharma Science Business Overview
Table 105. Strides Pharma Science Soft Capsules Drugs CMO Product
Table 106. Strides Pharma Science Revenue in Soft Capsules Drugs CMO Business (2018-2023) & (US$ Million)
Table 107. Strides Pharma Science Recent Developments
Table 108. Lonza (Capsugel) Company Details
Table 109. Lonza (Capsugel) Business Overview
Table 110. Lonza (Capsugel) Soft Capsules Drugs CMO Product
Table 111. Lonza (Capsugel) Revenue in Soft Capsules Drugs CMO Business (2018-2023) & (US$ Million)
Table 112. Lonza (Capsugel) Recent Developments
Table 113. Soft Gel Technologies Company Details
Table 114. Soft Gel Technologies Business Overview
Table 115. Soft Gel Technologies Soft Capsules Drugs CMO Product
Table 116. Soft Gel Technologies Revenue in Soft Capsules Drugs CMO Business (2018-2023) & (US$ Million)
Table 117. Soft Gel Technologies Recent Developments
Table 118. Sirio Pharma Company Details
Table 119. Sirio Pharma Business Overview
Table 120. Sirio Pharma Soft Capsules Drugs CMO Product
Table 121. Sirio Pharma Revenue in Soft Capsules Drugs CMO Business (2018-2023) & (US$ Million)
Table 122. Sirio Pharma Recent Developments
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Soft Capsules Drugs CMO Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Soft Capsules Drugs CMO Market Share by Type: 2022 VS 2033
Figure 3. Gelatin Type Features
Figure 4. Non-animal Type Features
Figure 5. Global Soft Capsules Drugs CMO Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Soft Capsules Drugs CMO Market Share by Application: 2022 VS 2033
Figure 7. Health Supplements Case Studies
Figure 8. Pharmaceutical Case Studies
Figure 9. Others Case Studies
Figure 10. Soft Capsules Drugs CMO Report Years Considered
Figure 11. Global Soft Capsules Drugs CMO Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Soft Capsules Drugs CMO Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Soft Capsules Drugs CMO Market Share by Region: 2022 VS 2033
Figure 14. Global Soft Capsules Drugs CMO Market Share by Players in 2022
Figure 15. Global Top Soft Capsules Drugs CMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soft Capsules Drugs CMO as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Soft Capsules Drugs CMO Revenue in 2022
Figure 17. North America Soft Capsules Drugs CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Soft Capsules Drugs CMO Market Share by Type (2018-2033)
Figure 19. North America Soft Capsules Drugs CMO Market Share by Application (2018-2033)
Figure 20. North America Soft Capsules Drugs CMO Market Share by Country (2018-2033)
Figure 21. United States Soft Capsules Drugs CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Soft Capsules Drugs CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Soft Capsules Drugs CMO Market Size YoY (2018-2033) & (US$ Million)
Figure 24. Europe Soft Capsules Drugs CMO Market Share by Type (2018-2033)
Figure 25. Europe Soft Capsules Drugs CMO Market Share by Application (2018-2033)
Figure 26. Europe Soft Capsules Drugs CMO Market Share by Country (2018-2033)
Figure 27. Germany Soft Capsules Drugs CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Soft Capsules Drugs CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Soft Capsules Drugs CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Soft Capsules Drugs CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Soft Capsules Drugs CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Soft Capsules Drugs CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. China Soft Capsules Drugs CMO Market Size YoY (2018-2033) & (US$ Million)
Figure 34. China Soft Capsules Drugs CMO Market Share by Type (2018-2033)
Figure 35. China Soft Capsules Drugs CMO Market Share by Application (2018-2033)
Figure 36. Asia Soft Capsules Drugs CMO Market Size YoY (2018-2033) & (US$ Million)
Figure 37. Asia Soft Capsules Drugs CMO Market Share by Type (2018-2033)
Figure 38. Asia Soft Capsules Drugs CMO Market Share by Application (2018-2033)
Figure 39. Asia Soft Capsules Drugs CMO Market Share by Region (2018-2033)
Figure 40. Japan Soft Capsules Drugs CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. South Korea Soft Capsules Drugs CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. China Taiwan Soft Capsules Drugs CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Soft Capsules Drugs CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Soft Capsules Drugs CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Soft Capsules Drugs CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Soft Capsules Drugs CMO Market Size YoY (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Soft Capsules Drugs CMO Market Share by Type (2018-2033)
Figure 48. Middle East, Africa, and Latin America Soft Capsules Drugs CMO Market Share by Application (2018-2033)
Figure 49. Middle East, Africa, and Latin America Soft Capsules Drugs CMO Market Share by Country (2018-2033)
Figure 50. Brazil Soft Capsules Drugs CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Mexico Soft Capsules Drugs CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Turkey Soft Capsules Drugs CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Soft Capsules Drugs CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Israel Soft Capsules Drugs CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. GCC Countries Soft Capsules Drugs CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Catalent Revenue Growth Rate in Soft Capsules Drugs CMO Business (2018-2023)
Figure 57. Aenova Revenue Growth Rate in Soft Capsules Drugs CMO Business (2018-2023)
Figure 58. Nature's Bounty Revenue Growth Rate in Soft Capsules Drugs CMO Business (2018-2023)
Figure 59. Procaps Revenue Growth Rate in Soft Capsules Drugs CMO Business (2018-2023)
Figure 60. Patheon (Thermo Fisher Scientific) Revenue Growth Rate in Soft Capsules Drugs CMO Business (2018-2023)
Figure 61. IVC Revenue Growth Rate in Soft Capsules Drugs CMO Business (2018-2023)
Figure 62. EuroCaps Revenue Growth Rate in Soft Capsules Drugs CMO Business (2018-2023)
Figure 63. Captek Revenue Growth Rate in Soft Capsules Drugs CMO Business (2018-2023)
Figure 64. Strides Pharma Science Revenue Growth Rate in Soft Capsules Drugs CMO Business (2018-2023)
Figure 65. Lonza (Capsugel) Revenue Growth Rate in Soft Capsules Drugs CMO Business (2018-2023)
Figure 66. Soft Gel Technologies Revenue Growth Rate in Soft Capsules Drugs CMO Business (2018-2023)
Figure 67. Sirio Pharma Revenue Growth Rate in Soft Capsules Drugs CMO Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries